186 related articles for article (PubMed ID: 24794045)
1. Apelin receptor: its responsiveness to stretch mechanisms and its potential for cardiovascular therapy.
Scimia MC; Blass BE; Koch WJ
Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):733-41. PubMed ID: 24794045
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening.
McAnally D; Siddiquee K; Sharir H; Qi F; Phatak S; Li JL; Berg E; Fishman J; Smith L
SLAS Discov; 2017 Aug; 22(7):867-878. PubMed ID: 28314120
[TBL] [Abstract][Full Text] [Related]
3. APJ acts as a dual receptor in cardiac hypertrophy.
Scimia MC; Hurtado C; Ray S; Metzler S; Wei K; Wang J; Woods CE; Purcell NH; Catalucci D; Akasaka T; Bueno OF; Vlasuk GP; Kaliman P; Bodmer R; Smith LH; Ashley E; Mercola M; Brown JH; Ruiz-Lozano P
Nature; 2012 Aug; 488(7411):394-8. PubMed ID: 22810587
[TBL] [Abstract][Full Text] [Related]
4. GPCR structure and function relationship: identification of a biased apelin receptor mutant.
Ban T; Li X; Ma X; Yang H; Song Y; Sun Y; Shen M; Li N; Zhang MY; Ma Y; Zhong W; Zhang M; Hu LA
Biochem J; 2018 Dec; 475(23):3813-3826. PubMed ID: 30409826
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors.
Reiter E; Ahn S; Shukla AK; Lefkowitz RJ
Annu Rev Pharmacol Toxicol; 2012; 52():179-97. PubMed ID: 21942629
[TBL] [Abstract][Full Text] [Related]
6. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
Huang Z; He L; Chen Z; Chen L
J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
[TBL] [Abstract][Full Text] [Related]
7. Heterodimerization of apelin and opioid receptor-like 1 receptors mediates apelin-13-induced G protein biased signaling.
Chen J; Wang Z; Zhang R; Yin H; Wang P; Wang C; Jiang Y
Life Sci; 2023 Sep; 328():121892. PubMed ID: 37364634
[TBL] [Abstract][Full Text] [Related]
8. [Biased Signaling through G Protein-coupled Receptors].
Kurose H
Yakugaku Zasshi; 2022; 142(10):1091-1101. PubMed ID: 36184444
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and In Vivo Evaluation of a Small-Molecule APJ (Apelin Receptor) Agonist, BMS-986224, as a Potential Treatment for Heart Failure.
Gargalovic P; Wong P; Onorato J; Finlay H; Wang T; Yan M; Crain E; St-Onge S; Héroux M; Bouvier M; Xu C; Chen XQ; Generaux C; Lawrence M; Wexler R; Gordon D
Circ Heart Fail; 2021 Mar; 14(3):e007351. PubMed ID: 33663236
[TBL] [Abstract][Full Text] [Related]
10. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
Chen X; Bai B; Tian Y; Du H; Chen J
J Biol Chem; 2014 Nov; 289(45):31173-87. PubMed ID: 25271156
[TBL] [Abstract][Full Text] [Related]
11. The hypotensive effect of activated apelin receptor is correlated with β-arrestin recruitment.
Besserer-Offroy É; Bérubé P; Côté J; Murza A; Longpré JM; Dumaine R; Lesur O; Auger-Messier M; Leduc R; Marsault É; Sarret P
Pharmacol Res; 2018 May; 131():7-16. PubMed ID: 29530600
[TBL] [Abstract][Full Text] [Related]
12. Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction.
Chen J; Chen X; Li S; Jiang Y; Mao H; Zhang R; Ji B; Yan M; Cai X; Wang C
Redox Biol; 2020 Sep; 36():101629. PubMed ID: 32863206
[TBL] [Abstract][Full Text] [Related]
13. Β-arrestin: a signaling molecule and potential therapeutic target for heart failure.
Noor N; Patel CB; Rockman HA
J Mol Cell Cardiol; 2011 Oct; 51(4):534-41. PubMed ID: 21074538
[TBL] [Abstract][Full Text] [Related]
14. Beta-arrestin-biased ligands at seven-transmembrane receptors.
Violin JD; Lefkowitz RJ
Trends Pharmacol Sci; 2007 Aug; 28(8):416-22. PubMed ID: 17644195
[TBL] [Abstract][Full Text] [Related]
15. The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin.
Lee DK; Ferguson SS; George SR; O'Dowd BF
Biochem Biophys Res Commun; 2010 Apr; 395(2):185-9. PubMed ID: 20353754
[TBL] [Abstract][Full Text] [Related]
16. beta-arrestin-biased agonism at the beta2-adrenergic receptor.
Drake MT; Violin JD; Whalen EJ; Wisler JW; Shenoy SK; Lefkowitz RJ
J Biol Chem; 2008 Feb; 283(9):5669-76. PubMed ID: 18086673
[TBL] [Abstract][Full Text] [Related]
17. Biased signalling: the instinctive skill of the cell in the selection of appropriate signalling pathways.
Liu Y; Yang Y; Ward R; An S; Guo XX; Li W; Xu TR
Biochem J; 2015 Sep; 470(2):155-67. PubMed ID: 26348905
[TBL] [Abstract][Full Text] [Related]
18. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist.
Brame AL; Maguire JJ; Yang P; Dyson A; Torella R; Cheriyan J; Singer M; Glen RC; Wilkinson IB; Davenport AP
Hypertension; 2015 Apr; 65(4):834-40. PubMed ID: 25712721
[TBL] [Abstract][Full Text] [Related]
19. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
